Brainlab Observes World Cancer Day with Message of Education and Innovation

Brainlab AG Brainlab AG, a global leader in cancer-fighting medical technology, showed solidarity with the World Cancer Day campaign 'We Can. I Can.' by releasing a video in which employees share how they personally impact cancer. The three-year World Cancer Day campaign, outlines actions that people can take to prevent cancer, improve survival rates and reduce the impact cancer has on individuals, families and communities.

"Our research and development teams are constantly exploring ways to create less invasive cancer treatments, and making those treatments available to as many people as possible, even in the remote corners of the globe," said Stefan Vilsmeier, CEO and President of Brainlab. "Within our company, we are committed to disease prevention by providing a healthy work environment and educating and encouraging our employees to make healthy lifestyle choices both at work and home."

According to the Union for International Cancer Control (UICC), the global cancer epidemic is significant and is set to rise. Currently, there are 8.2 million cancer deaths per year worldwide, almost half of which are patients aged 30 to 69. The global occurrence is expected to rise to 13.2 million per year by 2030 with global cost of care estimated at $458 billion.(1,2,3,)

Through cross-disciplinary technologies bridging neuroscience and oncology, and not-for-profit initiatives spanning underserved regions around the globe, Brainlab products and services help clinicians personalize medical treatments, reduce risk to healthy tissue and advance cancer survival rates and improve quality of life. Technologies like Adaptive Hybrid Surgery and Multiple Brain Metastases SRS are available to assist in the treatment of cancer patients while corporate support of the Right.Brain Foundation e.V., brings neuronavigation technology and training to remote areas around the globe.

Corporate collaboration with leading cancer institutions around the globe, including Jefferson Hospital for Neuroscience, Rush University Medical Center and UCLA Medical Center in the U.S. and Charité - Universitätsmedizin Berlin and Klinikum der Ludwig-Maximilians-Universität Munich in Germany continue to foster innovation while advancing awareness and prevention of cancerous conditions of the brain and body.

"Brainlab is passionate about and proud of the contributions we make each and every day in the fight against cancer," concluded Vilsmeier. "The company and all of our employees will continue to increase our participation in cancer research and impact on treatment. World Cancer Day is a wonderful opportunity for us to demonstrate our commitment. Together We Can. Treat. Fight. Win."

About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in 1989, Brainlab has over 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 19 offices worldwide, including 320 research & development engineers, who form a crucial part of the product development team.

About World Cancer Day
A truly global event taking place every year on February 4, World Cancer Day unites the world's population in the fight against cancer.

It aims to prevent millions of preventable deaths each year by raising awareness and education about the disease, pressing governments and individuals across the world to take action.

1. About. (n.d.). Retrieved January 28, 2016, from http://www.worldcancerday.org/about
2. About UICC. (n.d.). Retrieved January 28, 2016, from http://www.uicc.org/priorities
3. Cancer Explained. (n.d.). Retrieved January 26, 2016, from http://www.worldcancerday.org/sites/wcd/files/private/130128_Cancer_Backgrounder.pdf

Most Popular Now

Gait Assessed with Body-Worn Sensors may…

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the...

Applications for the G4A Global Accelera…

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and...

Siemens Healthineers Fully on Track to M…

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR...

How Blockchain Technology will Change th…

Opinion Article by Michael Krusche, founder and CEO of K&C. Let's imagine a world where all medical information about a patient is securely kept within a single system, and they can...

The Big Ethical Questions for Artificial…

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential...

How to Build GDPR and HIPAA Compliant He…

The adoption of cloud and mobile technologies in healthcare is disrupting the services delivery models, and responsibilities and risks for involved actors. By their very nature, eHealth applications collect and...

Computers Equal Radiologists in Assessin…

Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led...

International Masters's in Medical Infor…

The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI)in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

Novartis Launches FocalView App, Providi…

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data...

Consultation: Transformation Health and …

The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care...

Data in the EU: Commission Steps Up Effo…

The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal...

Philips Expands its Sleep & Respirat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has...